FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry and represents application of substituted nitrocatechols of formula 
for prevention or treatment of disorders, associated with central and peripheral nervous system, which obtain use from inhibition of catechol-O-methyltransferase (COMT), in accordance with schedule of dosing in the range from one time per three days to one time per week.
EFFECT: obtaining composition for prevention or treatment of disorders, associated with central and peripheral nervous system.
45 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMT INHIBITOR DOSAGE REGIMEN | 2007 |
|
RU2518483C2 |
| INTRODUCTION MODE FOR NITROCATECHOLS | 2011 |
|
RU2639131C2 |
| NITROCATECHOL DERIVATIVES AS COMP INHIBITORS | 2006 |
|
RU2441001C2 |
| PHARMACEUTICAL PREPARATIONS CONTAINING NITRO CATECHINE DERIVATIVES, AND METHODS FOR PREPARING THEREOF | 2010 |
|
RU2701731C2 |
| TARTRATE DERIVATIVES APPLIED AS BLOOD COAGULATION FACTOR IXA INHIBITORS | 2007 |
|
RU2446160C2 |
| ALLOSTERIC MODULATORS OF METABOLIC GLUTAMATE RECEPTORS | 2004 |
|
RU2360902C2 |
| TRIAZOLE DERIVATIVES | 2006 |
|
RU2416605C2 |
| NEW CATECHIN DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING CATECHIN DERIVATIVE, USING CATECHIN DERIVATIVE AND USING PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2459812C2 |
| NOVEL PYRAZOLE DERIVATIVES | 2014 |
|
RU2682247C2 |
| DERIVATIVES OF BENZANILIDE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION EXHIBITING ANTAGONISM TO 5-HT RECEPTORS | 1992 |
|
RU2077535C1 |
